Dr. Langen received her Dipl.-Biol. with an informatics minor from RWTH Aachen University, Germany, and wrote her graduate thesis in radiation biology at the German Aerospace Center (DLR) in Cologne, Germany. Moving to Sweden, she earned her Ph.D. in bioscience at Chalmers University of Technology. Her dissertation on radiation biomarker screening for normal tissue exposure was awarded the Assar Gabrielsson Award for best thesis in experimental research. She completed her postdoc training at University of Gothenburg, Sweden, where she pioneered age and sex bias research and translational chronobiology to improve pre-clinical radiation research. For this purpose, she also established a bioinformatics collaboration to apply machine learning and genetic algorithms to radiation biomarker discovery.
During her training, Dr. Langen has gained experience with unbound radionuclides and labeled radiopharmaceuticals, drug combination therapy of patient derived xenografts, external beam radiotherapy, and accelerated heavy ions. She has been on prolonged research visits to the HIMAC-NIRS facility in Chiba, Japan, and the Institut de Biologie Physico-Chimique (IBPC) in the Campus Curie in Paris, France. Dr. Langen is Vice Chair of the Scholars-In-Training Committee of the Radiation Research Society and founding member of the Initiative Radiation Researchers for Equity, Diversity, and Inclusivity.
She joined the Story Lab to improve cancer therapy using superoxide dismutase mimetics as radioprotectors and enhancers of radioimmune therapy.